AAUM (Average Assets Under Management) of ₹2,259.32 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 71.2% | 70.2% | ▼ -1.0% |
| Healthcare Services | 26.9% | 26.5% | ▼ -0.4% |
| Healthcare Equipment & Supplies | 0.6% | 0.6% | ● -0.1% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 70.2% | 71.2% | ▲ +1.0% |
| Healthcare Services | 26.5% | 27.9% | ▲ +1.4% |
| Healthcare Equipment & Supplies | 0.6% | 0.5% | ● -0.1% |
Comparing Jun 2026 → Jul 2026
| # | Stock | Sector | Weight (Jul 2026) |
|---|---|---|---|
| 1 | Jupiter Life Line Hospitals Limited ₹72.10 Cr |
Healthcare Services | 2.45% |
| 2 | Torrent Pharmaceuticals Limited ₹67.11 Cr |
Pharmaceuticals & Biotechnology | 2.28% |
| 3 | Apollo Hospitals Enterprise Limited ₹46.31 Cr |
Healthcare Services | 1.58% |
| # | Stock | Sector | Last Weight (Jun 2026) |
|---|---|---|---|
| 1 | Jupiter Life Line Hospitals Ltd ₹7.10 Cr |
Healthcare Services | 0.27% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹268.82 Cr |
Pharmaceuticals & Biotechnology | 7.16% | 9.14% | +1.98% |
| 2 | Dr. Reddy's Laboratories Limited ₹56.48 Cr |
Pharmaceuticals & Biotechnology | 1.04% | 1.92% | +0.88% |
| 3 | Biocon Limited ₹59.19 Cr |
Pharmaceuticals & Biotechnology | 1.17% | 2.01% | +0.84% |
| 4 | Neuland Laboratories Limited ₹99.98 Cr |
Pharmaceuticals & Biotechnology | 2.93% | 3.40% | +0.47% |
| # | Stock | Sector | Jun 2026 | Jul 2026 | Change |
|---|---|---|---|---|---|
| 1 | Acutaas Chemicals Ltd ₹105.26 Cr |
Pharmaceuticals & Biotechnology | 4.58% | 3.58% | -1.00% |
| 2 | Max Healthcare Institute Limited ₹141.56 Cr |
Healthcare Services | 5.57% | 4.82% | -0.75% |
| 3 | Lupin Limited ₹137.24 Cr |
Pharmaceuticals & Biotechnology | 5.26% | 4.67% | -0.59% |
| 4 | Cipla Limited ₹136.28 Cr |
Pharmaceuticals & Biotechnology | 5.19% | 4.64% | -0.55% |
| 5 | Fortis Healthcare Limited ₹81.92 Cr |
Healthcare Services | 3.18% | 2.79% | -0.39% |
| 6 | Krishna Institute Of Medical Sciences Limited ₹79.24 Cr |
Healthcare Services | 3.07% | 2.70% | -0.37% |
| 7 | Aster DM Healthcare Limited ₹138.21 Cr |
Healthcare Services | 5.05% | 4.70% | -0.35% |
| 8 | Alkem Laboratories Limited ₹107.84 Cr |
Pharmaceuticals & Biotechnology | 4.00% | 3.67% | -0.33% |
| 9 | IPCA Laboratories Limited ₹94.68 Cr |
Pharmaceuticals & Biotechnology | 3.53% | 3.22% | -0.31% |
| 10 | Sun Pharmaceutical Industries Limited ₹283.86 Cr |
Pharmaceuticals & Biotechnology | 9.96% | 9.66% | -0.30% |
37 stocks — Jul 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹283.86 Cr |
Pharmaceuticals & Biotechnology |
9.66%
|
|
| 2 |
₹268.82 Cr |
Pharmaceuticals & Biotechnology |
9.14%
|
|
| 3 |
₹141.56 Cr |
Healthcare Services |
4.82%
|
|
| 4 |
₹138.21 Cr |
Healthcare Services |
4.70%
|
|
| 5 |
₹137.24 Cr |
Pharmaceuticals & Biotechnology |
4.67%
|
|
| 6 |
₹136.28 Cr |
Pharmaceuticals & Biotechnology |
4.64%
|
|
| 7 |
₹107.84 Cr |
Pharmaceuticals & Biotechnology |
3.67%
|
|
| 8 |
₹105.26 Cr |
Pharmaceuticals & Biotechnology |
3.58%
|
|
| 9 |
₹104.52 Cr |
Pharmaceuticals & Biotechnology |
3.56%
|
|
| 10 |
₹99.98 Cr |
Pharmaceuticals & Biotechnology |
3.40%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.